Global Non-opioid Pain Patches Market Research Report 2020

Global Non-opioid Pain Patches Market Research Report 2020

Table of Contents
1 Non-opioid Pain Patches Market Overview
1.1 Product Overview and Scope of Non-opioid Pain Patches
1.2 Non-opioid Pain Patches Segment by Type
1.2.1 Global Non-opioid Pain Patches Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Lidocaine Patch
1.2.3 Diclofenac Patch
1.2.4 Methyl Salicylate Patch
1.2.5 Capsaicin Patch
1.2.6 Ketoprofen Patch
1.2.7 Other
1.3 Non-opioid Pain Patches Segment by Application
1.3.1 Non-opioid Pain Patches Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital Pharmacies
1.3.3 Independent Pharmacies & Drug Stores
1.3.4 Online Pharmacies
1.4 Global Non-opioid Pain Patches Market Size Estimates and Forecasts
1.4.1 Global Non-opioid Pain Patches Revenue 2015-2026
1.4.2 Global Non-opioid Pain Patches Sales 2015-2026
1.4.3 Non-opioid Pain Patches Market Size by Region: 2020 Versus 2026
2 Global Non-opioid Pain Patches Market Competition by Manufacturers
2.1 Global Non-opioid Pain Patches Sales Market Share by Manufacturers (2015-2020)
2.2 Global Non-opioid Pain Patches Revenue Share by Manufacturers (2015-2020)
2.3 Global Non-opioid Pain Patches Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Non-opioid Pain Patches Manufacturing Sites, Area Served, Product Type
2.5 Non-opioid Pain Patches Market Competitive Situation and Trends
2.5.1 Non-opioid Pain Patches Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Non-opioid Pain Patches Players (Opinion Leaders)
3 Non-opioid Pain Patches Retrospective Market Scenario by Region
3.1 Global Non-opioid Pain Patches Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Non-opioid Pain Patches Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Non-opioid Pain Patches Market Facts & Figures by Country
3.3.1 North America Non-opioid Pain Patches Sales by Country
3.3.2 North America Non-opioid Pain Patches Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Non-opioid Pain Patches Market Facts & Figures by Country
3.4.1 Europe Non-opioid Pain Patches Sales by Country
3.4.2 Europe Non-opioid Pain Patches Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Non-opioid Pain Patches Market Facts & Figures by Region
3.5.1 Asia Pacific Non-opioid Pain Patches Sales by Region
3.5.2 Asia Pacific Non-opioid Pain Patches Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Non-opioid Pain Patches Market Facts & Figures by Country
3.6.1 Latin America Non-opioid Pain Patches Sales by Country
3.6.2 Latin America Non-opioid Pain Patches Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Non-opioid Pain Patches Market Facts & Figures by Country
3.7.1 Middle East and Africa Non-opioid Pain Patches Sales by Country
3.7.2 Middle East and Africa Non-opioid Pain Patches Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Non-opioid Pain Patches Historic Market Analysis by Type
4.1 Global Non-opioid Pain Patches Sales Market Share by Type (2015-2020)
4.2 Global Non-opioid Pain Patches Revenue Market Share by Type (2015-2020)
4.3 Global Non-opioid Pain Patches Price Market Share by Type (2015-2020)
4.4 Global Non-opioid Pain Patches Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Non-opioid Pain Patches Historic Market Analysis by Application
5.1 Global Non-opioid Pain Patches Sales Market Share by Application (2015-2020)
5.2 Global Non-opioid Pain Patches Revenue Market Share by Application (2015-2020)
5.3 Global Non-opioid Pain Patches Price by Application (2015-2020)
6 Company Profiles and Key Figures in Non-opioid Pain Patches Business
6.1 Pfizer
6.1.1 Corporation Information
6.1.2 Pfizer Description, Business Overview and Total Revenue
6.1.3 Pfizer Non-opioid Pain Patches Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Pfizer Products Offered
6.1.5 Pfizer Recent Development
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Non-opioid Pain Patches Production Sites and Area Served
6.2.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.2.3 GlaxoSmithKline Non-opioid Pain Patches Sales, Revenue and Gross Margin (2015-2020)
6.2.4 GlaxoSmithKline Products Offered
6.2.5 GlaxoSmithKline Recent Development
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Non-opioid Pain Patches Production Sites and Area Served
6.3.2 Johnson & Johnson Description, Business Overview and Total Revenue
6.3.3 Johnson & Johnson Non-opioid Pain Patches Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Johnson & Johnson Products Offered
6.3.5 Johnson & Johnson Recent Development
6.4 Novartis AG
6.4.1 Novartis AG Non-opioid Pain Patches Production Sites and Area Served
6.4.2 Novartis AG Description, Business Overview and Total Revenue
6.4.3 Novartis AG Non-opioid Pain Patches Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Novartis AG Products Offered
6.4.5 Novartis AG Recent Development
6.5 Mylan N.V.
6.5.1 Mylan N.V. Non-opioid Pain Patches Production Sites and Area Served
6.5.2 Mylan N.V. Description, Business Overview and Total Revenue
6.5.3 Mylan N.V. Non-opioid Pain Patches Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Mylan N.V. Products Offered
6.5.5 Mylan N.V. Recent Development
6.6 Teva Pharmaceutical Industries
6.6.1 Teva Pharmaceutical Industries Non-opioid Pain Patches Production Sites and Area Served
6.6.2 Teva Pharmaceutical Industries Description, Business Overview and Total Revenue
6.6.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Teva Pharmaceutical Industries Products Offered
6.6.5 Teva Pharmaceutical Industries Recent Development
6.7 Hisamitsu Pharmaceutical
6.6.1 Hisamitsu Pharmaceutical Non-opioid Pain Patches Production Sites and Area Served
6.6.2 Hisamitsu Pharmaceutical Description, Business Overview and Total Revenue
6.6.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Hisamitsu Pharmaceutical Products Offered
6.7.5 Hisamitsu Pharmaceutical Recent Development
6.8 TEH SENG Pharmaceutical
6.8.1 TEH SENG Pharmaceutical Non-opioid Pain Patches Production Sites and Area Served
6.8.2 TEH SENG Pharmaceutical Description, Business Overview and Total Revenue
6.8.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Sales, Revenue and Gross Margin (2015-2020)
6.8.4 TEH SENG Pharmaceutical Products Offered
6.8.5 TEH SENG Pharmaceutical Recent Development
6.9 Teikoku Seiyaku
6.9.1 Teikoku Seiyaku Non-opioid Pain Patches Production Sites and Area Served
6.9.2 Teikoku Seiyaku Description, Business Overview and Total Revenue
6.9.3 Teikoku Seiyaku Non-opioid Pain Patches Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Teikoku Seiyaku Products Offered
6.9.5 Teikoku Seiyaku Recent Development
6.10 IBSA Institut Biochimque SA
6.10.1 IBSA Institut Biochimque SA Non-opioid Pain Patches Production Sites and Area Served
6.10.2 IBSA Institut Biochimque SA Description, Business Overview and Total Revenue
6.10.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Sales, Revenue and Gross Margin (2015-2020)
6.10.4 IBSA Institut Biochimque SA Products Offered
6.10.5 IBSA Institut Biochimque SA Recent Development
6.11 Acorda Therapeutics
6.11.1 Acorda Therapeutics Non-opioid Pain Patches Production Sites and Area Served
6.11.2 Acorda Therapeutics Non-opioid Pain Patches Description, Business Overview and Total Revenue
6.11.3 Acorda Therapeutics Non-opioid Pain Patches Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Acorda Therapeutics Products Offered
6.11.5 Acorda Therapeutics Recent Development
6.12 Allergan PLC
6.12.1 Allergan PLC Non-opioid Pain Patches Production Sites and Area Served
6.12.2 Allergan PLC Non-opioid Pain Patches Description, Business Overview and Total Revenue
6.12.3 Allergan PLC Non-opioid Pain Patches Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Allergan PLC Products Offered
6.12.5 Allergan PLC Recent Development
6.13 Endo International
6.13.1 Endo International Non-opioid Pain Patches Production Sites and Area Served
6.13.2 Endo International Non-opioid Pain Patches Description, Business Overview and Total Revenue
6.13.3 Endo International Non-opioid Pain Patches Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Endo International Products Offered
6.13.5 Endo International Recent Development
7 Non-opioid Pain Patches Manufacturing Cost Analysis
7.1 Non-opioid Pain Patches Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Non-opioid Pain Patches
7.4 Non-opioid Pain Patches Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Non-opioid Pain Patches Distributors List
8.3 Non-opioid Pain Patches Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Non-opioid Pain Patches Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Non-opioid Pain Patches by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Non-opioid Pain Patches by Type (2021-2026)
10.2 Non-opioid Pain Patches Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Non-opioid Pain Patches by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Non-opioid Pain Patches by Application (2021-2026)
10.3 Non-opioid Pain Patches Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Non-opioid Pain Patches by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Non-opioid Pain Patches by Region (2021-2026)
10.4 North America Non-opioid Pain Patches Estimates and Projections (2021-2026)
10.5 Europe Non-opioid Pain Patches Estimates and Projections (2021-2026)
10.6 Asia Pacific Non-opioid Pain Patches Estimates and Projections (2021-2026)
10.7 Latin America Non-opioid Pain Patches Estimates and Projections (2021-2026)
10.8 Middle East and Africa Non-opioid Pain Patches Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Non-opioid Pain Patches Sales (K Pcs) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Non-opioid Pain Patches Sales (K Pcs) Comparison by Application: 2020 VS 2026
Table 3. Global Non-opioid Pain Patches Market Size by Type (K Pcs) (US$ Million) (2020 VS 2026)
Table 4. Global Key Non-opioid Pain Patches Manufacturers Covered in This Study
Table 5. Global Non-opioid Pain Patches Sales (K Pcs) by Manufacturers (2015-2020)
Table 6. Global Non-opioid Pain Patches Sales Share by Manufacturers (2015-2020)
Table 7. Global Non-opioid Pain Patches Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Non-opioid Pain Patches Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Non-opioid Pain Patches Average Price (USD/Pcs) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Non-opioid Pain Patches Sales Sites and Area Served
Table 11. Manufacturers Non-opioid Pain Patches Product Types
Table 12. Global Non-opioid Pain Patches Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Non-opioid Pain Patches by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-opioid Pain Patches as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Non-opioid Pain Patches Players
Table 16. Global Non-opioid Pain Patches Sales (K Pcs) by Region (2015-2020)
Table 17. Global Non-opioid Pain Patches Sales Market Share by Region (2015-2020)
Table 18. Global Non-opioid Pain Patches Revenue (Million US$) by Region (2015-2020)
Table 19. Global Non-opioid Pain Patches Revenue Market Share by Region (2015-2020)
Table 20. North America Non-opioid Pain Patches Sales by Country (2015-2020) (K Pcs)
Table 21. North America Non-opioid Pain Patches Sales Market Share by Country (2015-2020)
Table 22. North America Non-opioid Pain Patches Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Non-opioid Pain Patches Revenue Market Share by Country (2015-2020)
Table 24. Europe Non-opioid Pain Patches Sales by Country (2015-2020) (K Pcs)
Table 25. Europe Non-opioid Pain Patches Sales Market Share by Country (2015-2020)
Table 26. Europe Non-opioid Pain Patches Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Non-opioid Pain Patches Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Non-opioid Pain Patches Sales by Region (2015-2020) (K Pcs)
Table 29. Asia Pacific Non-opioid Pain Patches Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Non-opioid Pain Patches Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Non-opioid Pain Patches Revenue Market Share by Region (2015-2020)
Table 32. Latin America Non-opioid Pain Patches Sales by Country (2015-2020) (K Pcs)
Table 33. Latin America Non-opioid Pain Patches Sales Market Share by Country (2015-2020)
Table 34. Latin America Non-opioid Pain Patches Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Non-opioid Pain Patches Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Non-opioid Pain Patches Sales by Country (2015-2020) (K Pcs)
Table 37. Middle East and Africa Non-opioid Pain Patches Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Non-opioid Pain Patches Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Non-opioid Pain Patches Revenue Market Share by Country (2015-2020)
Table 40. Global Non-opioid Pain Patches Sales (K Pcs) by Type (2015-2020)
Table 41. Global Non-opioid Pain Patches Sales Share by Type (2015-2020)
Table 42. Global Non-opioid Pain Patches Revenue (Million US$) by Type (2015-2020)
Table 43. Global Non-opioid Pain Patches Revenue Share by Type (2015-2020)
Table 44. Global Non-opioid Pain Patches Price (USD/Pcs) by Type (2015-2020)
Table 45. Global Non-opioid Pain Patches Sales (K Pcs) by Application (2015-2020)
Table 46. Global Non-opioid Pain Patches Sales Market Share by Application (2015-2020)
Table 47. Global Non-opioid Pain Patches Sales Growth Rate by Application (2015-2020)
Table 48. Pfizer Non-opioid Pain Patches Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Non-opioid Pain Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 51. Pfizer Main Product
Table 52. Pfizer Recent Development
Table 53. GlaxoSmithKline Non-opioid Pain Patches Corporation Information
Table 54. GlaxoSmithKline Corporation Information
Table 55. GlaxoSmithKline Non-opioid Pain Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 56. GlaxoSmithKline Main Product
Table 57. GlaxoSmithKline Recent Development
Table 58. Johnson & Johnson Non-opioid Pain Patches Corporation Information
Table 59. Johnson & Johnson Corporation Information
Table 60. Johnson & Johnson Non-opioid Pain Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 61. Johnson & Johnson Main Product
Table 62. Johnson & Johnson Recent Development
Table 63. Novartis AG Non-opioid Pain Patches Corporation Information
Table 64. Novartis AG Corporation Information
Table 65. Novartis AG Non-opioid Pain Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 66. Novartis AG Main Product
Table 67. Novartis AG Recent Development
Table 68. Mylan N.V. Non-opioid Pain Patches Corporation Information
Table 69. Mylan N.V. Corporation Information
Table 70. Mylan N.V. Non-opioid Pain Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 71. Mylan N.V. Main Product
Table 72. Mylan N.V. Recent Development
Table 73. Teva Pharmaceutical Industries Non-opioid Pain Patches Corporation Information
Table 74. Teva Pharmaceutical Industries Corporation Information
Table 75. Teva Pharmaceutical Industries Non-opioid Pain Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Teva Pharmaceutical Industries Main Product
Table 77. Teva Pharmaceutical Industries Recent Development
Table 78. Hisamitsu Pharmaceutical Non-opioid Pain Patches Corporation Information
Table 79. Hisamitsu Pharmaceutical Corporation Information
Table 80. Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Hisamitsu Pharmaceutical Main Product
Table 82. Hisamitsu Pharmaceutical Recent Development
Table 83. TEH SENG Pharmaceutical Non-opioid Pain Patches Corporation Information
Table 84. TEH SENG Pharmaceutical Corporation Information
Table 85. TEH SENG Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. TEH SENG Pharmaceutical Main Product
Table 87. TEH SENG Pharmaceutical Recent Development
Table 88. Teikoku Seiyaku Non-opioid Pain Patches Corporation Information
Table 89. Teikoku Seiyaku Corporation Information
Table 90. Teikoku Seiyaku Non-opioid Pain Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Teikoku Seiyaku Main Product
Table 92. Teikoku Seiyaku Recent Development
Table 93. IBSA Institut Biochimque SA Non-opioid Pain Patches Corporation Information
Table 94. IBSA Institut Biochimque SA Corporation Information
Table 95. IBSA Institut Biochimque SA Non-opioid Pain Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. IBSA Institut Biochimque SA Main Product
Table 97. IBSA Institut Biochimque SA Recent Development
Table 98. Acorda Therapeutics Non-opioid Pain Patches Corporation Information
Table 99. Acorda Therapeutics Corporation Information
Table 100. Acorda Therapeutics Non-opioid Pain Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Acorda Therapeutics Main Product
Table 102. Acorda Therapeutics Recent Development
Table 103. Allergan PLC Non-opioid Pain Patches Corporation Information
Table 104. Allergan PLC Corporation Information
Table 105. Allergan PLC Non-opioid Pain Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Allergan PLC Main Product
Table 107. Allergan PLC Recent Development
Table 108. Endo International Non-opioid Pain Patches Corporation Information
Table 109. Endo International Corporation Information
Table 110. Endo International Non-opioid Pain Patches Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Endo International Main Product
Table 112. Endo International Recent Development
Table 113. Sales Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Non-opioid Pain Patches Distributors List
Table 116. Non-opioid Pain Patches Customers List
Table 117. Market Key Trends
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Global Non-opioid Pain Patches Sales (K Pcs) Forecast by Type (2021-2026)
Table 121. Global Non-opioid Pain Patches Sales Market Share Forecast by Type (2021-2026)
Table 122. Global Non-opioid Pain Patches Revenue (Million US$) Forecast by Type (2021-2026)
Table 123. Global Non-opioid Pain Patches Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 124. Global Non-opioid Pain Patches Sales (K Pcs) Forecast by Application (2021-2026)
Table 125. Global Non-opioid Pain Patches Revenue (Million US$) Forecast by Application (2021-2026)
Table 126. Global Non-opioid Pain Patches Sales (K Pcs) Forecast by Region (2021-2026)
Table 127. Global Non-opioid Pain Patches Sales Market Share Forecast by Region (2021-2026)
Table 128. Global Non-opioid Pain Patches Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Global Non-opioid Pain Patches Revenue Market Share Forecast by Region (2021-2026)
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Non-opioid Pain Patches
Figure 2. Global Non-opioid Pain Patches Sales Market Share by Type: 2020 VS 2026
Figure 3. Lidocaine Patch Product Picture
Figure 4. Diclofenac Patch Product Picture
Figure 5. Methyl Salicylate Patch Product Picture
Figure 6. Capsaicin Patch Product Picture
Figure 7. Ketoprofen Patch Product Picture
Figure 8. Other Product Picture
Figure 9. Global Non-opioid Pain Patches Consumption Market Share by Application: 2020 VS 2026
Figure 10. Hospital Pharmacies
Figure 11. Independent Pharmacies & Drug Stores
Figure 12. Online Pharmacies
Figure 13. Global Non-opioid Pain Patches Market Size 2015-2026 (US$ Million)
Figure 14. Global Non-opioid Pain Patches Sales Capacity (K Pcs) (2015-2026)
Figure 15. Global Non-opioid Pain Patches Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Non-opioid Pain Patches Sales Share by Manufacturers in 2020
Figure 17. Global Non-opioid Pain Patches Revenue Share by Manufacturers in 2019
Figure 18. The Global 5 and 10 Largest Players: Market Share by Non-opioid Pain Patches Revenue in 2019
Figure 19. Non-opioid Pain Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Non-opioid Pain Patches Sales Market Share by Region (2015-2020)
Figure 21. Global Non-opioid Pain Patches Sales Market Share by Region in 2019
Figure 22. Global Non-opioid Pain Patches Revenue Market Share by Region (2015-2020)
Figure 23. Global Non-opioid Pain Patches Revenue Market Share by Region in 2019
Figure 24. North America Non-opioid Pain Patches Sales Market Share by Country in 2019
Figure 25. North America Non-opioid Pain Patches Revenue Market Share by Country in 2019
Figure 26. U.S. Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 27. U.S. Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Canada Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 29. Canada Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. Europe Non-opioid Pain Patches Sales Market Share by Country in 2019
Figure 31. Europe Non-opioid Pain Patches Revenue Market Share by Country in 2019
Figure 32. Germany Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 33. Germany Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. France Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. France Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. U.K. Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.K. Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Italy Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Italy Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Russia Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Russia Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Asia Pacific Non-opioid Pain Patches Sales Market Share by Region in 2019
Figure 43. Asia Pacific Non-opioid Pain Patches Revenue Market Share by Region in 2019
Figure 44. China Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. China Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Japan Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Japan Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. South Korea Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. South Korea Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. India Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. India Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Australia Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Australia Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Taiwan Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Taiwan Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Indonesia Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Indonesia Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Thailand Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. Thailand Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Malaysia Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Malaysia Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Philippines Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Philippines Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Vietnam Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Vietnam Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Latin America Non-opioid Pain Patches Sales Market Share by Country in 2019
Figure 67. Latin America Non-opioid Pain Patches Revenue Market Share by Country in 2019
Figure 68. Mexico Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Mexico Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Brazil Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Brazil Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Argentina Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Argentina Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Middle East and Africa Non-opioid Pain Patches Sales Market Share by Country in 2019
Figure 75. Middle East and Africa Non-opioid Pain Patches Revenue Market Share by Country in 2019
Figure 76. Turkey Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Turkey Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Saudi Arabia Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Saudi Arabia Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. U.A.E Non-opioid Pain Patches Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. U.A.E Non-opioid Pain Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Sales Market Share of Non-opioid Pain Patches by Type (2015-2020)
Figure 83. Sales Market Share of Non-opioid Pain Patches by Type in 2019
Figure 84. Revenue Share of Non-opioid Pain Patches by Type (2015-2020)
Figure 85. Revenue Market Share of Non-opioid Pain Patches by Type in 2019
Figure 86. Global Non-opioid Pain Patches Sales Growth by Type (2015-2020) (K Pcs)
Figure 87. Global Non-opioid Pain Patches Sales Market Share by Application (2015-2020)
Figure 88. Global Non-opioid Pain Patches Sales Market Share by Application in 2019
Figure 89. Global Revenue Share of Non-opioid Pain Patches by Application (2015-2020)
Figure 90. Global Revenue Share of Non-opioid Pain Patches by Application in 2020
Figure 91. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Mylan N.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Hisamitsu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. TEH SENG Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Teikoku Seiyaku Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. IBSA Institut Biochimque SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Acorda Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Allergan PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Endo International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Price Trend of Key Raw Materials
Figure 105. Manufacturing Cost Structure of Non-opioid Pain Patches
Figure 106. Manufacturing Process Analysis of Non-opioid Pain Patches
Figure 107. Non-opioid Pain Patches Industrial Chain Analysis
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Porter's Five Forces Analysis
Figure 111. North America Non-opioid Pain Patches Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 112. North America Non-opioid Pain Patches Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Europe Non-opioid Pain Patches Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 114. Europe Non-opioid Pain Patches Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Latin America Non-opioid Pain Patches Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 116. Latin America Non-opioid Pain Patches Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Middle East and Africa Non-opioid Pain Patches Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 118. Middle East and Africa Non-opioid Pain Patches Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Asia Pacific Non-opioid Pain Patches Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 120. Asia Pacific Non-opioid Pain Patches Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs